Pelican Therapeutics develops biologic agents that represent the next generation of TNF based immunotherapy. It operates as a biotechnology company that focuses on the development and commercialization of monoclonal antibody and fusion protein-based therapies that are designed to activate the immune system.

It was incorporated in 2009 and is